We're on a mission to help people with diabetes live better lives.
Intellin has been designed to help people living with diabetes. It uses a clinically validated logic engine to actively monitor patients’ diabetes management and uses their clinical history to highlight their individual risk of developing diabetes-related complications, e.g. cardiovascular disease, kidney disease, amputation or blindness. Its algorithms analyse users’ health data to provide individually tailored, clinically validated educational content and guidance to help people with diabetes manage their condition more effectively.
The app has achieved 500,000 global downloads, with over 70,000 active monthly users. It is free of charge with an option to increase functionality by purchasing additional connectivity which allows connection to other devices such as activity monitors, blood glucose, blood pressure monitors, Bluetooth enabled scales, Apple Health, etc. There is also a dashboard which allows patients to link to their clinician to allow remote monitoring.
As an SME at the very beginning of our revenue journey there are many opportunities for us to address but having the capacity expand and meet these opportunities can be a limiting factor. Therefore, we wish to collaborate with others who are able to fund new initiatives and also work with us to further expand our capability, both technical and commercial.
Helios Health, Asklepios, Sana Kliniken, Rhon-Klinikum, Egis, Kantonspital Winterthur, AZ Glorieux, Health Proc Europe, Vienna University Hospital, Sanofi, Bayer, Merck, ELGA, VizenzGruppe
Challenges / Needs
Entering German & Austrian Market, Investors
Products & Services
There are currently no products.
Glasshouse, Alderley Park, Cheshire, UK, Alderley Park, SK10 4ZE, United Kingdom